The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRockwood Strat. Regulatory News (RKW)

Share Price Information for Rockwood Strat. (RKW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 274.00
Bid: 270.00
Ask: 278.00
Change: 0.00 (0.00%)
Spread: 8.00 (2.963%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 274.00
RKW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

7 Oct 2022 07:00

RNS Number : 0887C
Rockwood Strategic PLC
07 October 2022
 

Rockwood Strategic plc ("RKW" or "the Company")

Trading Update

Rockwood Strategic plc (LSE: RKW) today provides an update on current trading ahead of publication of its unaudited results for the six months ended 30 September 2022 (the "Period").

Financial highlights

Net Asset Value (NAV) Total Return in the Period of -10.4% to 1446.7p/share which compares to the FTSE Small Cap (ex-ITs) of -20.3% and FTSE AIM All Share of -22.6%.

Total Shareholder Return in the Period was -0.35%. At Period end the Company traded at a discount of 2.2% to NAV.

No. 2 ranked fund by Total Shareholder Return in the AIC UK Small Companies sector over the last 6 and 12 months, achieving 0.9% positive performance whilst the FTSE Small Cap Index (ex-ITs) fell 26.6% and the AIM All-share even more, down 35.2% (LTM).

NAV Total Return performance in the three years to 30 September 2022 of 44.3% which compares to the FTSE Small Cap (ex-ITs) of 6%. The Total Shareholder Return in the same three year period was 65%, No.1 rank in the AIC UK Small Companies sector.

Investment gains realised in the Lakes Distillery Bond delivered a 21.6% IRR and £3.1m cash.

Net cash of £2.4m at the end of the Period (representing 6.6% of NAV). We are anticipating a number of H2 investee dividends alongside an announced return of capital from Smoove.

 

Portfolio highlights

Seven new investments were made across a range of industry sectors such as City Pub Group Plc within consumer, Argentex Group Plc in FX services, Galliford Try Holdings Plc in construction, RM Plc in educational services and Finsbury Food Group Plc in food manufacturing. All trade at a deep discount to our assessment of intrinsic value; all have material upside to historic or industry profit margins; and all are highly cash generative. We have identified catalysts to unlock, create or realise shareholder value in each.

Significantly positive share price performance from Crestchic Plc (up 63.6% during the Period, finishing at 28.7% of NAV) which, following our engagement in 2020-21 led to the company's 'transformation plan', divisional disposal and Board/management evolution. At the end of September the company released another material increase to profit expectations from its record order book. We maintain a positive outlook on the investment.

Across the portfolio, there were strong results announced from a range of other holdings, despite the challenging macro-economic environment, including Centaur Media, MC Saatchi, Van Elle and Smoove:

 

Centaur Media Plc: Sales up 8%, Ebitda up 55%, net cash £14.2m (Interim results)

 

M&C Saatchi Plc: Sales up 10%, PBT up 52%, net cash £39.7m (Interim results)

 

Van Elle Holdings Plc: Sales up 48%, Ebitda up 133%, net cash £5.9m (Final results)

 

Smoove Plc : Sales up 13%, net cash £20m (Final results)

Pressure Technologies Plc released a disappointing update at the very end of the Period and we are actively engaged with management.

The Investment Manager is comfortable that overall the portfolio is well financed. In summary 9 holdings have a net cash position, 4 are lowly leveraged and 2 have elevated debt.

The Investment Manager has highlighted that due to the weak market conditions experienced in 2022, the valuation of UK smaller companies have become very depressed. Their pipeline of potential investments has grown as multiple opportunities emerge to deploy capital in the period ahead.

 

Corporate development

Successful migration of the Company from the AIM to a premium listing on the main market of the London Stock Exchange.

Appointment of Paul Dudley as Non-Executive Director

 

Richard Staveley, Fund Manager, Harwood Capital LLP said:

"2022 is rapidly becoming a year in financial markets that few will forget, despite their best efforts. Bond and equity markets have struggled with levels of inflation not experienced for decades and the tightening monetary policy stance of the world's central banks. We see challenging market conditions and a difficult economic environment as delivering a "target rich environment" (Lt. Pete Mitchell) for our differentiated approach. We are focused on the future, making highly selective investments that will drive returns for Rockwood Strategic over our investment time horizon and find our pipeline for new potential investments building at pace. The ability of the portfolio companies to improve profitability via 'self-help' should mitigate and, in many cases, more than offset difficult end markets or cost pressures. This dynamic is being demonstrated most clearly at Crestchic. For all holdings we can identify a large 'margin of safety' in their equity undervaluation and catalysts to drive shareholder value"

The latest Investor Presentation and Q3 Factsheet are now available at www.rockwoodstrategic.co.uk.

For further information, please contact:

Rockwood Strategic plc

Chairman

 

Noel Lamb

 

020 7264 4444

 

Harwood Capital LLP

Investment Manager

 

 

Christopher Hart

 

020 7640 3200

Singer Capital Markets Advisory LLP

 

 

 

 James Maxwell

Alex Bond

James Fischer

 

 020 7496 3000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKABQABDDAKK
Date   Source Headline
21st May 20247:00 amRNSIssue of Equity
20th May 20244:16 pmRNSNet Asset Value(s)
16th May 20247:00 amRNSInvestor Presentation via Investor Meet Company
13th May 20241:58 pmRNSNet Asset Value(s)
7th May 20244:40 pmRNSNet Asset Value(s)
1st May 20246:02 pmRNSNet Asset Value(s)
29th Apr 20243:31 pmRNSNet Asset Value(s)
29th Apr 20247:00 amRNSIssue of Equity
26th Apr 20247:00 amRNSIssue of Equity
24th Apr 20247:00 amRNSIssue of Equity
23rd Apr 20247:00 amRNSIssue of Equity
22nd Apr 20244:33 pmRNSNet Asset Value(s)
15th Apr 20243:55 pmRNSNet Asset Value(s)
10th Apr 20247:01 amRNSDirector/PDMR Shareholding
10th Apr 20247:00 amRNSIssue of Equity
8th Apr 20244:19 pmRNSNet Asset Value(s)
2nd Apr 20246:07 pmRNSNet Asset Value(s)
2nd Apr 20247:00 amRNSIssue of Equity
25th Mar 20243:55 pmRNSNet Asset Value(s)
22nd Mar 20247:00 amRNSIssue of Equity
20th Mar 20247:00 amRNSIssue of Equity
18th Mar 20244:47 pmRNSNet Asset Value(s)
18th Mar 20247:00 amRNSIssue of Equity
15th Mar 20247:00 amRNSIssue of Equity
14th Mar 20247:00 amRNSIssue of Equity
13th Mar 20247:00 amRNSIssue of Equity
11th Mar 20244:12 pmRNSNet Asset Value(s)
7th Mar 20247:00 amRNSIssue of Equity
4th Mar 20242:59 pmRNSNet Asset Value(s)
1st Mar 20244:05 pmRNSNet Asset Value(s)
26th Feb 20243:22 pmRNSNet Asset Value(s)
22nd Feb 20247:00 amRNSIssue of Equity
19th Feb 20243:07 pmRNSNet Asset Value(s)
15th Feb 20247:00 amRNSIssue of Equity, Investment Manager Shareholding
13th Feb 20247:00 amRNSBlock Listing Approval
9th Feb 20247:00 amRNSBlock Listing Application
8th Feb 20247:00 amRNSIssue of Equity and TVR
5th Feb 20242:30 pmRNSNet Asset Value(s)
2nd Feb 20247:00 amRNSIssue of Equity
1st Feb 20244:02 pmRNSNet Asset Value(s)
1st Feb 20247:00 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSIssue of Equity
29th Jan 20243:23 pmRNSNet Asset Value(s)
23rd Jan 20247:00 amRNSIssue of Equity
22nd Jan 20243:30 pmRNSNet Asset Value(s)
17th Jan 20247:00 amRNSIssue of Equity
15th Jan 20242:34 pmRNSNet Asset Value(s)
15th Jan 20247:00 amRNSIssue of Equity
12th Jan 20247:00 amRNSIssue of Equity
10th Jan 20247:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.